SHLT — SHL Telemedicine Cashflow Statement
0.000.00%
- $39.92m
- $40.45m
- $57.08m
- 70
- 75
- 26
- 58
Annual cashflow statement for SHL Telemedicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.7 | 0.278 | -13.9 | 0.215 | -6.86 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.034 | 0.203 | 14.9 | -3.68 | -1.09 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.27 | -0.727 | -6.45 | -3.74 | -1.24 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 10.8 | 4.68 | 0.185 | -0.073 | -1.5 |
| Capital Expenditures | -1.97 | -1.77 | -3.26 | -6.9 | -5.49 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 4.45 | -5.88 | -37.7 | 0.471 | -3.85 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 2.47 | -7.65 | -41 | -6.43 | -9.35 |
| Financing Cash Flow Items | — | — | — | -0.13 | -1.91 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -11.9 | 0.723 | 51.1 | -2.28 | 13.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.65 | -1.93 | 10.7 | -10.4 | 2.21 |